Cipla Limited (NSE:CIPLA) — Market Cap & Net Worth

$11.44 Billion USD · Rs1.06 Trillion INR · Rank #2017

Market Cap & Net Worth: Cipla Limited (CIPLA)

Cipla Limited (NSE:CIPLA) has a market capitalization of $11.44 Billion (Rs1.06 Trillion) as of May 2, 2026. Listed on the NSE stock exchange, this India-based company holds position #2017 globally and #79 in its home market, demonstrating a 5.93% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cipla Limited's stock price Rs1309.60 by its total outstanding shares 807780677 (807.78 Million). Analyse Cipla Limited operating cash flow efficiency to see how efficiently the company converts income to cash.

Cipla Limited Market Cap History: 2015 to 2026

Cipla Limited's market capitalization history from 2015 to 2026. Data shows growth from $5.44 Billion to $11.44 Billion (6.79% CAGR).

Index Memberships

Cipla Limited is a constituent of 9 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NIFTY PHARMA CNXPHARMA	$86.64 Billion	13.20%	#2 of 20
NIFTY GROWTH SECTORS 15 NI15	$263.61 Billion	4.34%	#7 of 15
NIFTY 100 NIFTY100	$2.04 Trillion	0.56%	#64 of 100
NIFTY100 EQUAL WEIGHT NIFTY100EW	$1.79 Trillion	0.64%	#51 of 99
NIFTY 200 NIFTY200	$2.56 Trillion	0.45%	#73 of 200
NIFTY 500 NIFTY500	$3.11 Trillion	0.37%	#74 of 500
NIFTY HEALTHCARE NIFTYHEALTHCARE	$102.93 Billion	11.11%	#3 of 20
Nifty Low Volatility 50 NIFTYLVI	$997.46 Billion	1.15%	#24 of 48
NIFTY TOTAL MARKET NIFTYTOTALMKT	$3.20 Trillion	0.36%	#73 of 750

Weight: Cipla Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Cipla Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Cipla Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.05x

Cipla Limited's market cap is 0.05 times its annual revenue

Industry average: 1.04x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.25x

Cipla Limited's market cap is 0.25 times its annual earnings

Industry average: 8.30x Lower than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$4.74 Billion	$135.48 Billion	$13.60 Billion	0.03x	0.35x
2017	$5.09 Billion	$143.34 Billion	$10.06 Billion	0.04x	0.51x
2018	$4.38 Billion	$151.05 Billion	$14.11 Billion	0.03x	0.31x
2019	$4.05 Billion	$163.23 Billion	$15.28 Billion	0.02x	0.27x
2020	$6.96 Billion	$170.81 Billion	$15.47 Billion	0.04x	0.45x
2021	$8.07 Billion	$191.21 Billion	$24.05 Billion	0.04x	0.34x
2022	$9.25 Billion	$217.08 Billion	$25.17 Billion	0.04x	0.37x
2023	$10.83 Billion	$225.59 Billion	$28.02 Billion	0.05x	0.39x
2024	$13.36 Billion	$255.37 Billion	$41.22 Billion	0.05x	0.32x
2025	$13.20 Billion	$272.67 Billion	$52.73 Billion	0.05x	0.25x

Competitor Companies of CIPLA by Market Capitalization

Companies near Cipla Limited in the global market cap rankings as of May 2, 2026.

Key companies related to Cipla Limited by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#499	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#525	Zoetis Inc	NYSE:ZTS	$50.31 Billion	$114.16
#526	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$50.29 Billion	CN¥53.88
#572	GALDERMA GROUP AG	NYSE:GALDY	$45.88 Billion	$42.09

Cipla Limited Historical Marketcap From 2015 to 2026

Between 2015 and today, Cipla Limited's market cap moved from $5.44 Billion to $ 11.44 Billion, with a yearly change of 6.79%.

Year	Market Cap	Change (%)
2026	Rs11.44 Billion	-13.35%
2025	Rs13.20 Billion	-1.16%
2024	Rs13.36 Billion	+23.36%
2023	Rs10.83 Billion	+17.02%
2022	Rs9.25 Billion	+14.64%
2021	Rs8.07 Billion	+15.92%
2020	Rs6.96 Billion	+71.79%
2019	Rs4.05 Billion	-7.38%
2018	Rs4.38 Billion	-14.08%
2017	Rs5.09 Billion	+7.43%
2016	Rs4.74 Billion	-12.83%
2015	Rs5.44 Billion	--

End of Day Market Cap According to Different Sources

On May 2nd, 2026 the market cap of Cipla Limited was reported to be:

Source	Market Cap
Yahoo Finance	$11.44 Billion USD
MoneyControl	$11.44 Billion USD
MarketWatch	$11.44 Billion USD
marketcap.company	$11.44 Billion USD
Reuters	$11.44 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Cipla Limited

NSE:CIPLA India Drug Manufacturers - Specialty & Generic

Market Cap

$11.44 Billion

Rs1.06 Trillion INR

Market Cap Rank

#2017 Global

#79 in India

Share Price

Rs1309.60

Change (1 day)

-0.61%

52-Week Range

Rs1192.40 - Rs1663.60

All Time High

Rs1683.00